Scrip's Five Must-Know Things - 26 February 2024

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer takes strategic steps to cut debt; AbbVie confirms internal appointment as CEO; another RIPK1 setback for Denali/Sanofi; new biotech reality in China; and ex-Daiichi Sankyo CEO shares insights into tough decisions. https://scrip.citeline.com/SC149846/Quick-Listen-Scrips-Five-MustKnow-Things